Toggle Menu
Join our Community
Support ToI and remove
all
ads
Learn more
English
Français
עברית
Get The Daily Edition
Account
Sign In
Sign in
Join our Community
Open Search form
Toggle Menu
Israel & the Region
Jewish Times
Israel Inside
Tech Israel
Real Estate
Israel
The Blogs
Podcasts
Video
Newsletters
The Daily Edition
What Matters Most Today
Tech Israel
Updates from Silicon Wadi
Real Estate Israel
Monthly Update
The Weekend Edition
The Best Reads of the Week
Weekly Highlights
Choice Voices From The Blogs
Partners
Atlanta
Atlanta Jewish Times
North New Jersey
The Jewish Standard
Pittsburgh
Jewish Chronicle
United Kingdom
The Jewish News
Australia
The Australian Jewish News
For Publishers
Become a Partner
Open Search form
Toggle Menu
search
Input search
Clear search input
English
Français
עברית
Latest Articles
Latest Alerts
Israel & the Region
Jewish Times
Israel Inside
Tech Israel
Real Estate
Israel
The Blogs
Podcasts
Video
Newsletters
The Daily Edition
What Matters Most Today
Tech Israel
Updates from Silicon Wadi
Real Estate Israel
Monthly Update
The Weekend Edition
The Best Reads of the Week
Weekly Highlights
Choice Voices From The Blogs
Partners
Atlanta
Atlanta Jewish Times
North New Jersey
The Jewish Standard
Pittsburgh
Jewish Chronicle
United Kingdom
The Jewish News
Australia
The Australian Jewish News
For Publishers
Become a Partner
Community
Join our community
Sign in
About The Times of Israel
Advertise on The Times of Israel
Contact us
Download our App
For IOS users
For Android users
Get the Daily Edition
submit
Follow us
© 2026 The Times of Israel , All Rights Reserved
Terms and conditions
Privacy policy
Input search
Clear search input
×
Moderna
Advertisement
April 11, 2023, 10:43 am
Moderna seeking to roll out vaccines for cancer, heart disease by end of decade
Regulatory review due to success in studies, and thanks to leap in progress made by development of mRNA COVID jab
By
ToI Staff
and
Agencies
October 7, 2022, 11:46 am
4th shots of Pfizer, Moderna vaccines provide near equal protection — Israeli study
Sheba-led research team says that 6 months after boosters, ‘antibody levels and cumulative vaccine efficacy do not differ between the two vaccines’
By
Nathan Jeffay
August 26, 2022, 5:20 pm
Moderna sues Pfizer, BioNTech over patents behind COVID vaccine
Massachusetts-based firm accuses rival and its partner of copyright infringement, filing suit in both US and German courts
By
Tom Murphy
July 18, 2022, 1:51 pm
Moderna’s new variant-busting COVID vaccine starting trial in Israel
Study will assess how well special shot built to be Omicron-proof protects against infection; expert says Israel helping lead way in ‘the future of the fight against the pandemic’
By
Nathan Jeffay
June 22, 2022, 11:37 pm
Moderna: Updated COVID booster is effective against Omicron subvariants
CEO says US biotech firm intends to submit new vaccine to regulators, will gear up to start supplying shots by August in anticipation of infection spike in the fall
By
AFP
June 8, 2022, 11:59 pm
Moderna says updated COVID booster protects against omicron
Vaccine reportedly triggers increased resistance across prior variants, although it’s unclear for how long; study performed on 437 people and not yet scientifically reviewed
By
LAURAN NEERGAARD
April 19, 2022, 2:41 pm
Moderna seeking to update COVID vaccine against Omicron by the fall
VP at US pharma firm says data showing shot it developed to help counter Beta variant ‘really give us hope’ that boosters can be adjusted for other coronavirus strains
By
LAURAN NEERGAARD
January 31, 2022, 8:17 pm
US grants full approval to Moderna’s COVID vaccine
‘The public can be assured that this vaccine was approved in keeping with the FDA’s rigorous scientific standards,’ says senior regulator
By
AP
and
ToI Staff
December 20, 2021, 4:11 pm
Moderna says its booster likely protects against Omicron
Lab tests show half-dose booster shot increased by 37 times the level of so-called neutralizing antibodies able to fight new strain of coronavirus
By
AP
November 30, 2021, 8:53 am
Moderna CEO predicts existing COVID vaccines less effective against Omicron
Stephane Bancel says there’s ‘no world’ in which protection will prove to be the same against new strain, says he expects a ‘material drop’
By
ToI Staff
November 27, 2021, 7:59 am
Moderna says it will develop booster shot for new COVID variant
Pharmaceutical company says it is also examining using a higher dose of its existing vaccine against Omicron
By
ToI Staff
November 26, 2021, 10:53 pm
BioNtech says it needs 2 weeks to determine vaccine’s effectiveness against Omicron
Firm that developed vaccine with Pfizer says it will have more data available next month, but has plans in motion to be able to mass-manufacture adapted inoculation
By
ToI Staff
October 25, 2021, 11:07 pm
Moderna says its low-dose COVID shot works for kids 6-11
Vaccine maker says it will soon share interim results of study with FDA and global regulators
By
LAURAN NEERGAARD
September 23, 2021, 3:58 pm
Moderna CEO predicts pandemic could be over in a year
Stephane Bancel says COVID shots will be okayed for infants and there will be enough doses by mid-2022 to inoculate everyone worldwide; thinks situation could come to resemble flu
By
ToI Staff
September 18, 2021, 8:52 am
Moderna beats Pfizer on long-term protection against hospitalization, study says
Accumulating research suggests vaccine’s superiority, possibly due to dosage level — 100 micrograms against 30 — or dosage interval, with Pfizer given 3 weeks apart and Moderna 4
By
AFP
Load More
Advertisement
close popup
Sign in or Join The Times of Israel Community
Paying ToI Community members are invited to comment on articles
Email address
*
Please use the following structure: example@domain.com
Continue
Or Continue with
By joining you agree to the
terms and conditions
back
close popup
Register to continue
Email address
*
Change
REGISTER
Or Continue with
back
close popup
Log in to continue
Email address
*
Something went wrong.
Please try again in a few minutes..
Continue
back
close popup
Sign in or Join The Times of Israel Community
You are currently registered. Please join The Times of Israel Community to comment and enjoy other Community benefits
Only ToI Community members can comment below articles
Email address
*
Password
*
Incorrect password. Please try again or choose an option below.
Forgot your password?
/
Send me a login link
Continue
Sign in without joining
Or Continue with
close popup
Check your email
We sent an email to you at
.
It has a link that will sign you in.
Click the link in that email to complete registration so you can comment.
back
close popup
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Email address
*
Please use the following structure: example@domain.com
JOIN NOW!
close popup
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to
. Once you're set up, you can start enjoying Community benefits and commenting.
Back to top
Never miss breaking news on Israel
Get notifications to stay updated
Stay updated
No thanks
You're subscribed
close popup
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Email address
Please use the following structure: example@domain.com
REGISTER OR SIGN IN
Or Continue with
By registering you agree to the
terms and conditions
. Once registered, you’ll receive our Daily Edition email for free.
Send me The Times of Israel Daily Edition
back
close popup
Register to continue
Email address
Change
REGISTER
Or Continue with
back
close popup
Log in to continue
Email address
Something went wrong.
Please try again in a few minutes..
Continue
back
close popup
Sign in or Register
Email address
*
Password
*
Incorrect password. Please try again or choose an option below.
Continue
I forgot my password
/
Send me a sign in link
Or Continue with
back
close popup
Check your email
We sent an email to you at
.
It has a link that will sign you in.
Click the link in that email to complete your registration.